of the 32 study patients followed after study ( range , 5 to 33 months ) , no patients in the ifn-alpha group developed an acquired immunodeficiency syndrome ( aids ) -defining opportunistic infection , compared with 5 patients in the placebo group ( p = 0.02 ) .
C0021735
ifn-alpha
C0001175
acquired immunodeficiency syndrome